SCHEMBL6744532

SCHEMBL6744532

Cc1cccc(C2=CCC=C2c2cc(F)c(S(C)(=O)=O)cc2F)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 1/20 0.35
CCR8 P51685 1/20 0.35
PTGS2 P35354 2/20 0.34
TGFBR1 P36897 6/20 0.33
NR1H2 P55055 2/20 0.33
NR1H3 Q13133 2/20 0.33
THRB P10828 2/20 0.33
GPR119 Q8TDV5 1/20 0.33
GHSR Q92847 2/20 0.32
KDR P35968 2/20 0.32
MAPK14 Q16539 2/20 0.32
ALOX5AP P20292 2/20 0.31
FEN1 P39748 2/20 0.31
CYP2A6 P11509 1/20 0.31
RIPK2 O43353 1/20 0.31
SIK1 P57059 1/20 0.30
SIK2 Q9H0K1 1/20 0.30
SIK3 Q9Y2K2 1/20 0.30
HCRTR1 O43613 1/20 0.30
HCRTR2 O43614 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6749801 0.79 NR1H2 (0.37) PTGS2NR1H2NR1H3GPR119ALOX5AP
SCHEMBL6746127 0.79 HTT (0.34) PTGS2GPR119
SCHEMBL6746680 0.78 NR1H2 (0.36) PTGS2NR1H2NR1H3
SCHEMBL6747157 0.78 TGFBR1 (0.37) CCR1CCR8PTGS2TGFBR1THRB
SCHEMBL6745201 0.77 ACLY (0.43) PTGS2NR1H2NR1H3ALOX5APFEN1
SCHEMBL6743464 0.77 PTGS2 (0.38) PTGS2NR1H2NR1H3
SCHEMBL6746763 0.76 NR1H2 (0.31) NR1H2NR1H3
SCHEMBL6743170 0.76 PTGS2 (0.48) PTGS2
SCHEMBL6732406 0.76 CCR1 (0.33) CCR1CCR8PTGS2TGFBR1NR1H2
SCHEMBL6735985 0.75 CYP2A6 (0.41) CCR1CCR8PTGS2TGFBR1NR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6699884-B2 ANTIINFLAMMATORY CYCLOOXYGENASE INHIBITORS. PHARMACIA CORPORATION 2004-03-02 US claimed
US-6699884-B2 ANTIINFLAMMATORY CYCLOOXYGENASE INHIBITORS. PHARMACIA CORPORATION 2004-03-02 US disclosed